Is NAD‑precursor supplementation (e.g., nicotinamide riboside, nicotinamide mononucleotide, or nicotinamide) safe and appropriate for children?

NAD Supplements for Children: Not Recommended

NAD-precursor supplements (nicotinamide riboside, nicotinamide mononucleotide) should not be used in children, as they are explicitly contraindicated for individuals under 18 years of age and lack any safety or efficacy data in pediatric populations. 1

Regulatory and Safety Warnings

• FDA labeling for nicotinamide mononucleotide explicitly states: "Not for use by individuals under the age of 18." 1
• No clinical trials have evaluated the safety, appropriate dosing, or efficacy of NR or NMN in children or adolescents 2, 3, 4, 5
• All published human studies of these supplements have been conducted exclusively in adults, primarily those aged 60-80 years 3, 4, 5

Standard Niacin (Vitamin B3) for Children

If there is a legitimate concern about NAD metabolism or niacin deficiency in a child, standard niacin (nicotinamide/nicotinic acid) should be used instead, with established pediatric dosing:

Parenteral Nutrition Dosing

• Infants up to 12 months: 4-6.8 mg/kg/day of niacin 6
• Children over 12 months: 17 mg/day of niacin 6

Dietary Reference Intakes

• Adolescents ≥14 years: Males 16 mg/day, Females 14 mg/day 7

Upper Limits in Children

• Nicotinic acid: 10 mg/day (due to flushing risk) 7
• Nicotinamide: 12.5 mg/kg body weight/day 7
• These limits are based on adult data with uncertainty factors applied; pediatric-specific upper limits are not well-established 7

Why Novel NAD Precursors Are Problematic in Children

Lack of Evidence

• The 25 published human trials of NR have shown "few clinically relevant effects" even in adults, with a tendency to exaggerate reported benefits 2
• Recent meta-analyses demonstrate no significant improvements in muscle mass, strength, or physical function in older adults 8

Potential Risks

• High-dose nicotinamide can alter DNA and protein methylation, affecting cellular transcriptome and proteome 9
• Chronic high-dose use raises concerns for epigenetic alterations, particularly problematic during growth and development 9
• Animal studies show NMN and NR can worsen atherosclerosis despite improving lipid profiles, with effects being dose-dependent 10
• Methylnicotinamide metabolites may play roles in disease processes that are poorly understood 9

Metabolic Complexity

• Most orally administered NMN and NR undergoes gut microbiota-mediated conversion to nicotinic acid rather than direct absorption 11
• The compounds are rapidly degraded and undergo enterohepatic circulation, making their metabolic fate unpredictable 11

Clinical Approach to NAD-Related Concerns in Children

If a child presents with symptoms potentially related to niacin deficiency (pellagra: cutaneous, gastrointestinal, neurologic symptoms):

1. Evaluate for true deficiency states requiring standard niacin supplementation at established pediatric doses 6
2. Consider underlying conditions: carcinoid syndrome, malabsorption, short bowel syndrome 6
3. Use standard multivitamin formulations containing age-appropriate niacin doses for at-risk patients 7
4. Avoid experimental NAD precursors (NR, NMN) that lack pediatric safety data and FDA approval for use under age 18 1

Common Pitfalls

• Do not prescribe trendy NAD-boosting supplements marketed for "anti-aging" or "longevity" to pediatric patients, as these are adult-focused products without pediatric indication 1, 2
• Do not assume safety based on adult studies, as children have different metabolic profiles and are undergoing critical developmental processes vulnerable to epigenetic alterations 9
• Nicotinamide (standard vitamin B3) has no reported toxicity at appropriate doses, making it the safer choice when supplementation is truly needed 6